0001193125-23-257260.txt : 20231017 0001193125-23-257260.hdr.sgml : 20231017 20231017065857 ACCESSION NUMBER: 0001193125-23-257260 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231017 FILED AS OF DATE: 20231017 DATE AS OF CHANGE: 20231017 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHINA LIFE INSURANCE CO LTD CENTRAL INDEX KEY: 0001268896 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] IRS NUMBER: 000000000 STATE OF INCORPORATION: F4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31914 FILM NUMBER: 231328434 BUSINESS ADDRESS: STREET 1: 16 FINANCIAL STREET STREET 2: XICHENG DISTRICT CITY: BEIJING STATE: F4 ZIP: 100033 BUSINESS PHONE: 861063633333 MAIL ADDRESS: STREET 1: 16 FINANCIAL STREET STREET 2: XICHENG DISTRICT CITY: BEIJING STATE: F4 ZIP: 100033 FORMER COMPANY: FORMER CONFORMED NAME: CHINE LIFE INSURANCE CO LTD DATE OF NAME CHANGE: 20031103 6-K 1 d568237d6k.htm FORM 6-K Form 6-K

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

October 17, 2023

 

 

China Life Insurance Company Limited

(Translation of registrant’s name into English)

 

 

16 Financial Street

Xicheng District

Beijing 100033, China

Tel: (86-10) 6363-3333

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F ☒   Form 40-F ☐

 

 

 

Commission File Number 001-31914

 

On October 17, 2023, China Life Insurance Company Limited issued an announcement in Chinese, the English translation of which is attached as Exhibit 99.1 hereto.

EXHIBIT LIST

 

Exhibit    Description
99.1    English translation of the announcement, dated October 17, 2023

Commission File Number 001-31914

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

        China Life Insurance Company Limited
    (Registrant)
    By:   /s/ Li Mingguang
October 17, 2023       (Signature)
   

Name:

Title:

  

Li Mingguang

Principal Executive Officer and Executive Director

 

 EX-99.1 2 d568237dex991.htm EX-99.1 EX-99.1

Commission File Number 001-31914

EXHIBIT 99.1

Announcement on the Resolution of the Thirtieth Meeting of the Seventh Session of the Board of Directors of China Life Insurance Company Limited

The thirtieth meeting (the “Meeting”) of the seventh session of the Board of Directors (the “Board”) of China Life Insurance Company Limited (the “Company”) was held on October 17 in Beijing. The directors were notified of the Meeting by way of a written notice dated October 11, 2023. Out of the Company’s eight directors, seven directors attended the Meeting. The following directors attended the Meeting in person, including Li Mingguang, executive director of the Company, and Wang Junhui and Zhuo Meijuan, non-executive directors of the Company. Lam Chi Kuen, Zhai Haitao, Huang Yiping and Chen Jie, independent directors of the Company, attended the Meeting by way of video conference. Bai Tao, chairman and executive director of the Company, was on leave for business and authorized in writing, Li Mingguang, executive director of the Company, to act on his behalf, cast the vote for him and preside over the Meeting. Supervisors and members of the management of the Company also attended the Meeting as non-voting delegates. The time, venue of the Meeting and the manner in which the Meeting was convened are in accordance with the Company Law of the People’s Republic of China and the provisions under relevant laws, administrative regulations, departmental rules, Articles of Association and Rules of Procedures for the Board of Directors of the Company.

The Meeting was presided over by executive director Mr. Li Mingguang. The directors who attended the Meeting unanimously passed the following resolution after sufficient review and discussion:

 

1.

The Proposal regarding Post-Investment Matters of Zhongcheng Project

Voting result: 8 for, 0 against, with no abstention

Board of Directors of China Life Insurance Company Limited

October 17, 2023